The enumeration of blood CD4+ (single-positive) T cells by flow cytometry is subject to errors such as counting CD4+ monocytes or CD4+CD8+ (double-positive) T cells as CD4+ T cells. Relatively accurate count can be obtained when CD4+ T cells are defined as CD3+CD4+CD8- mononuclear cells (MNCs), usin
Flow cytometric reticulocyte counting: a comparison between two methods
โ Scribed by M. Maconi; P. Danise; L. Cavalca; D. Formisano
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 87 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0887-8013
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The peripheral reticulocyte count is commonly used as an indicator of the erythropoietic activity of the bone marrow. Manual counting provides results with a high degree of inaccuracy and imprecision. Automation of counting is therefore needed. The increase in the number of methods available requires however that the results from the various methods agree with one another. The aim of our study was to evaluate the analytic performance of two automated hematology analyzers by a parallel study. We compared the analyzers between them and with manual counting. We enrolled in our study a total of 100 healthy subjects and an additional 80 patients affected by various hematological diseases. Difference between methods is statistically significant: the reference intervals of ADVIA2120 are higher than the Sysmex XEโ2100. The correlation between methods and correlation with the microscopic method are excellent and statistically significant. In conclusion, we can affirm that total automation of reticulocyte counts represents a definite improvement over microscopic counts. This study confirms the diversity of the reference intervals still exists in the new automated hematology analyzers. J. Clin. Lab. Anal. 24:252โ255, 2010. ยฉ 2010 WileyโLiss, Inc.
๐ SIMILAR VOLUMES
## Abstract ## Background: A flow cytometry count of reticulocytes (RET) provides information about distribution of signal emitted by reticulocyte RNA. A new method of determination of the RNA degradation rate in RET is provided. This technique allows one to determinate the age distribution of RET
Proliferating cells in tumors may be of considerable relevance in cancer therapy. Not only do such cells dictate the rate of tumor progression, but evidence exists that they may also play an important role in the diagnosis and prognosis of tumor regrowth. Consequently, the identification of this sub